The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies (Q61960641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

T Lind

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Mégraud

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P Unge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

E Bayerdörffer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C O'morain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Veldhuyzen Van Zanten

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

K D Bardhan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Hellblom

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Wrangstadh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

L Zeijlon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Cederberg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

248-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Rapid eradication of Helicobacter pylori infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2899%2970119-8

10.1016/S0016-5085(99)70119-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9922303%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference